Day: March 21, 2024
VANCOUVER, British Columbia, March 21, 2024 (GLOBE NEWSWIRE) — ELSE NUTRITION HOLDINGS INC. (BABY) (BABYF) (0YL.F) (“Else” or the “Company”), today announced that it plans to host a business update conference call at 10:30 a.m. Eastern Time on April 1, 2024 to discuss the Company’s financial results for the 2023 fiscal year ended December 31, 2023, as well as the Company’s corporate progress and other developments.
The conference call will be available via telephone by dialing toll free 1-877-704-4453 for U.S. callers or +1-201-389-0920 for international callers. A webcast of the call may be accessed at https://viavid.webcasts.com/starthere.jsp?ei=1661271&tp_key=87e7860827 or on the Investor Relations section of the Company’s website at https://investors.elsenutrition.com/.
A webcast replay will be...
TEN, Ltd. Announces Date of Fourth Quarter and Year End 2023 Results, Conference Call and Webcast
Written by Customer Service on . Posted in Public Companies.
ATHENS, Greece, March 21, 2024 (GLOBE NEWSWIRE) — TEN, Ltd. (“TEN” or the “Company”) (NYSE: TNP) a leading diversified crude, product and LNG tanker operator, today announced that the Company will report earnings for the fourth quarter and year ended on December 31, 2023, prior to the open of the market in New York on Wednesday, March 27, 2024.
That same day, at 12:00 p.m. Eastern Time, TEN will host a conference call to review the results as well as the management’s outlook for the business. The call, which will be hosted by TEN’s senior management, may contain information beyond that which is included in the earnings press release.
Conference Call Details:Participants should dial into the call 10 minutes before the scheduled time using the following numbers: 877-405-1226 (US Toll-Free Dial In) or +1 201-689-7823 (US and...
Awiqli® (once-weekly basal insulin icodec) recommended for approval for the treatment of diabetes by the European regulatory authorities
Written by Customer Service on . Posted in Public Companies.
Bagsværd, Denmark, 21 March 2024 – Novo Nordisk today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion, recommending marketing authorisation for Awiqli® (the brand name for once-weekly basal insulin icodec) for treatment of diabetes in adults.
The positive CHMP opinion is based on results from the ONWARDS phase 3a clinical trial programme. Once-weekly basal insulin icodec achieved superior blood sugar reduction1 (measured by a change in HbA1c) and superior Time in Range2 (time spent within recommended blood sugar range), compared with daily basal insulin in people with type 2 diabetes. In people with type 2 diabetes who have not previously been treated with insulin, overall observed rates of clinically significant or severe hypoglycaemia3 were below one...
Dogfish Head Craft Brewery to Launch Sippin’ & Flippin’ Giveaway, Winner to Receive All-Expenses Paid Trip to a Concert of Their Choice
Written by Customer Service on . Posted in Public Companies.
Sippin’ & Flippin’ to kick-off Dogfish Head’s month-long music celebration, which includes a partnership with Record Store Day, a host of sponsored concerts and events, and more.Dogfish Head’s Sippin’ & Flippin’ Concert GiveawayThroughout the month of April, in select independently owned record stores from coast-to-coast, Dogfish Head will hide commemorative, metallic-gold records among the shops’ stacks of vinyl. Lucky folks that stumble upon a golden record will not only win a swag bag full of goodies, but they will be entered for the chance to win the contest’s grand-prize trip – an all-expenses paid trip for two to a concert of their choosing.MILTON, Del., March 21, 2024 (GLOBE NEWSWIRE) — Self-proclaimed “beer geeks with a music problem,” Dogfish Head Craft Brewery announces Sippin’...
SPZI: JP 3E Holdings, Inc. Retains Accell Audit & Compliance, PA to Audit the Financial Statements
Written by Customer Service on . Posted in Public Companies.
JP 3E Holdings, Inc., formerly Spooz Inc., will become a Fully Reporting Company, Retaining Accell Audit & Compliance, PA in pursuit of Uplisting
CLEARWATER, Fla., March 21, 2024 (GLOBE NEWSWIRE) — JP 3E Holdings, Inc., formerly Spooz, Inc. (OTC: SPZI), retains Accell Audit & Compliance, PA to audit the company’s financials to become an SEC Fully Reporting company. This is the first step toward achieving its goal of uplisting first to the OTCQB. Accell is registered with the Public Company Accounting Oversight Board (PCAOB) and provides audit services to several hundred clients, from high-tech start-up companies to Fortune 500. Its current client portfolio includes numerous public and private companies across many industries, with operations on at least five continents.http://www.theaccellgroup.com/
Accell is a licensed...
Savaria Declares Monthly Dividend (Record Date Correction)
Written by Customer Service on . Posted in Dividend Reports And Estimates.
LAVAL, Quebec, March 21, 2024 (GLOBE NEWSWIRE) — Savaria Corporation (“Savaria”) (TSX: SIS) a global leader in the accessibility industry, declared today a dividend of 4.33 cents ($0.0433) per common share, in accordance with its monthly dividend policy, payable on April 10, 2024, to shareholders of record of the Corporation at the close of business on March 28, 2024. This is an eligible dividend within the meaning of the Income Tax Act.
About Savaria Corporation
Savaria Corporation (savaria.com) is a global leader in the accessibility industry. It provides accessibility solutions for the physically challenged to increase their comfort, their mobility and their independence. Its product line is one of the most comprehensive on the market. Savaria designs, manufactures, distributes and installs accessibility equipment, such as stairlifts...
Scilex Holding Company Announces New Out-of-Pocket Costs for Commercially Insured Patients
Written by Customer Service on . Posted in Public Companies.
PALO ALTO, Calif., March 21, 2024 (GLOBE NEWSWIRE) — Scilex Holding Company (Nasdaq: SCLX, “Scilex” or “Company”), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain, today announced that the out-of-pocket costs for its product portfolio for commercially insured patients is expected to be capped at $25 monthly, with certain eligible patients paying as low as $0. This applies to the Company’s postherpetic neuralgia pain product, ZTlido®, migraine product, ELYXYB®, and gout flare prophylaxis product, Gloperba®, which is expected to launch in the first half of 2024. Scilex has made significant investments to improve patient affordability and access to its products and continues to build on the Company’s...
No. 6/2024 – Course of the annual general meeting
Written by Customer Service on . Posted in Public Companies.
Nasdaq Copenhagen Nikolaj Plads 6 DK-1067 Copenhagen K
Copenhagen, 21 March 2024 ANNOUNCEMENT no. 6/2024
CEMAT A/SCompany reg. (CVR) no. 24 93 28 18Annual general meeting 2024
On 21 March 2024 at 1:00 pm the annual general meeting was held in Cemat A/S (the “Company”) at DLA Piper Denmark, Oslo Plads 2, 2100 Copenhagen Ø.
Pursuant to the Company’s articles of association, the Board of Directors had appointed attorney-at-law Martin Lavesen as chairman of the meeting.The management’s report on the Company’s activities during the past financial yearThe management’s report for the financial year 2023 was presented by management.
The annual general meeting took note of the management’s report for the financial year 2023.Presentation of the audited...
Red Pine Exploration Announces the Results of its Annual General Meeting, Provides Update & Grants Annual Stock Option Awards
Written by Customer Service on . Posted in Public Companies.
TORONTO, March 21, 2024 (GLOBE NEWSWIRE) — Red Pine Exploration Inc. (TSXV: RPX, OTCQB; RDEXF) (“Red Pine” or the “Company”) is pleased to announce the results of its Annual General Meeting of Shareholders (the “Meeting”) held virtually on March 12, 2024.
At the Meeting, the shareholders:elected Drew Anwyll, Gary O’Connor, Rachel Goldman, Paul Martin and Quentin Yarie as directors of the Company; and
reappointed MNP LLP, Chartered Professional Accountants as the Company’s auditors until the next annual meeting of shareholders, and to authorize the directors to set their renumeration.Mr. Paul Martin commented, “We are extremely fortunate to have added Gary O’Connor to the Board given his extensive experience in the evaluation and development of resources, including most recently at the Tower Gold project located in the Timmins...
US Capital Global Achieves Record-breaking Average of $2.2BN in Financing and Advisory Transactions Per Year over the Past Three Years
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
Closing 90 transactions totalling over $6.5 billion in 36 months, US Capital Global demonstrates substantial growth, further solidifying its position as a leading player in the global financial arena.Closing 90 transactions totalling over $6.5 billion in 36 monthsThat’s a record-breaking average of $2.2BN in Financing and Advisory transactions per year over the past three yearsSelection of Completed Transactionshe breadth and scale of transactions we facilitated underscore the strength of our global footprintSan Francisco, California, USA, March 21, 2024 (GLOBE NEWSWIRE) — US Capital Global proudly announces a landmark achievement, surpassing an average of $2.2 billion in debt and equity financings and advisory transactions per year over the past three years. Headquartered in San Francisco, with key offices...